These commercially available products, based on the development of two human adult stem cell lines designated as ACT-I and ACT-II, can be used to generate unlimited supplies of human white and brown fat, respectively, the company said. more

The company recently signed an agreement with Stemgent to market CellDesign's AdipoDesign Starter Kit and AdipoDesign MaxiKit.

The company was founded on the premise that the power of stem cells can be harnessed to improve the process of drug discovery. The company's scientists were the first to successfully demonstrate that stem cell-derived cell types were superior to traditional cell models in cell-based screening applications, CellDesign says.

CellDesign says scientists at the company apply their extensive expertise at controlling the complexity of the stem cell to create reproducible, physiologically-relevant cell models that are customized for specific screening purposes. CellDesign's goal is to make these reagents available to research scientists who have a need for high-quality, renewable, inexpensive and easy-to-use stem cell-based assays.